Curiously, four tyrosine kinase inhibitors and systemic lupus erythematosus (SLE) underline the phenotypic similarity between protein kinase inhibitors and autoimmune diseases in the network. This evidence concerns the gene WEE1 and systemic lupus erythematosus.